Ziyuan Chao

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation

R. McIntyre, Y. Ning, Kai Wu, 2022, Frontiers in Psychiatry.

The association between overweight/obesity and poor cognitive function is mediated by inflammation in patients with major depressive disorder.

Kai Wu, Yanling Zhou, Guohui Lao, 2022, Journal of affective disorders.

Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine

Y. Ning, Yanling Zhou, Chengyu Wang, 2021, Journal of neuroinflammation.

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial

Yanling Zhou, Chengyu Wang, Xiaofeng Lan, 2022, BMC Psychiatry.

Plasma Inflammatory Cytokines and Depressed Patients With Comorbid Pain: Improvement by Ketamine

Y. Ning, Yanling Zhou, Chengyu Wang, 2021 .

The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality.

R. McIntyre, Y. Ning, Kai Wu, 2021, Journal of psychiatric research.

Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.

Fan Zhang, Yanling Zhou, Chengyu Wang, 2023, Journal of the American Academy of Child and Adolescent Psychiatry.

The Effectiveness of Repeated Intravenous Ketamine on Subjective and Objective Psychosocial Function in Patients with Treatment-Resistant Depression and Suicidal Ideation.

R. McIntyre, Y. Ning, Yanling Zhou, 2022, Journal of affective disorders.